We’re showcasing our lead commercial pharma-grade, water-soluble CBD—GlyCBD™, a molecule that delivers the wellness benefits CBD is known for—at the Discovery & Development US Congress in San Diego, October 2–3, 2025 (Booth #52). Meet with our team to discuss molecule chemistry, formulation benefits, and competitive effectiveness across ingestible, topical, oral/intranasal mucosal and inhalable applications.
Trait Biosciences will be exhibiting at Discovery & Development US 2025 in San Diego on October 2–3, 2025, sharing how our water-soluble CBD ingredients support efficient absorption, consistent performance, and among others across multiple delivery formats. Visit us at Booth #52 to learn how GlyCBD™, our lead molecule within our Distilled™ brand of water-soluble cannabinoids, can simplify development pathways ranging from OTC and Rx-adjacent to beverage and nutraceutical applications. oxfordglobal.com
What we’ll cover at the booth
- Benefits of CBD solutions (vs. suspensions or emulsions): how solubility, stability, and dose uniformity impact real-world bioavailability and product consistency.
- Formulation pathways: ingestible (solid dose, gummies, beverages, tinctures), topical (creams, gels, sprays), oral/intranasal mucosal, and inhalable approaches.
- Quality and supply: pharma-grade quality standards and a global supply chain approach.
Who should stop by
R&D, CMC, and innovation leads in pharma/OTC, nutraceuticals, cosmeceuticals, beverages, and pet health.
Planning to attend?
Email us at info@traitbio.com to book a 15-minute slot at Booth #52 and bring your formulation questions.